Studies have shown that vitamin D attenuates fibrosis after myocardial infarction by inhibiting the TGF-β/Smads signaling pathway, and a combined metabolomics and transcriptomics analysis revealed that exogenous vitamin D supplementation also modulates AC6 [39, 40]. This evidence concerns the gene ADCY6 and myocardial infarction.